There are many people who wonder whether the Prevacid Class Action Lawsuit is worth pursuing. This class action lawsuit was brought against Amway Company. Amway is a direct selling company which sells toothpaste and other health care products. They also offer weight loss and other personal care products as well. The main product they sell is PPI (Payment Protection Insurance) and they have been accused of charging their customers with an excessive premium on their insurance policies. The class action lawsuit was filed by the Center for Medicare Services.
Prevacid Class Action Lawsuit
The Center for Medicare Services sent letters to more than twenty-five million families in America saying that their health premiums on their insurance policies were too high and therefore they should be able to join the class action lawsuit. The crux of the class action lawsuit is that the Amway and its related companies did not disclose information regarding the risks of PPI and did not make clear how the premiums would be taken out of the monthly paychecks of their customers.
In the event of an accident or illness, the policy holder would be liable for the cost of treatment. In light of this, the claim was that Amway failed to provide proper warnings and information that would help people make an informed decision on whether or not to purchase their insurance policies.
The Prevacid class action lawsuit is not one to relish, but rather it is one that need to be pursued.
There have been other Prevacid class action lawsuits, all of which have been successful in terms of getting the Amway and its related companies to reimburse the losses suffered by their clients. One of the lawsuits which resulted in the recovery of money was one which was filed by the wife of a deceased customer.
In this particular prevacid lawsuit, there were several plaintiffs who had lost their wages and were unable to continue working due to their inability to eat or drink.
The main issue in the case was that one of the men in the group had developed a kidney infection and was on painkillers for the pain he endured. He was not aware that he had such a dangerous illness, yet, on the day that his condition became critical, he went to the emergency room of his local hospital. A scan determined that he had a perforated ulcer in his abdomen, which was pressing against his liver and kidneys and preventing him from absorbing the vital liquids which were required to keep him alive.
The Prevacid class action lawsuit was brought by his wife.
They were determined to get some compensation for the medical bills that they had accumulated as a result of their husband’s illness, as well as the pain and suffering they had inflicted on him. It should be noted that their claims were ultimately denied, though they did win their first appeal. This second appeal was denied by the defendant’s side on the grounds that it did not show that there had been a ‘cautionary’ sign on the date of the accident.
The claim was subsequently rejected on the ground that no evidence existed that either the driver of the vehicle, or any other person was negligent in any way. The judge in the trial however agreed with the defendants that there was sufficient evidence that the man’s condition was caused by his failing to take adequate care of himself while driving..
While the Prevacid lawsuit was ongoing, a separate trial regarding the negligence of the manufacturer, Astrazeneca, was being held. There were claims being made that this manufacturer had designed the Prevacid tablets with defects which meant that the tablets were not absorbent and did not work as they were supposed to. At the time the tablets failed to work they would not allow the intestines to do their job, which is to absorb the liquids which are required for normal function of the body. The claim was that the manufacturer knew about the potential problems with the tablet and did nothing to resolve them, resulting in a condition which would ultimately leave the man extremely paralysed..
